Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDXCMDexcomGEHCGE HealthCareRMDResMed
Snapshot
Price$90.10$71.22$233.33
Market cap$27.49B$29.82B$30.41B
Valuation
P/E37.7x17.4x22.3x
Forward P/E26.9x19.8x19.1x
Growth
Revenue growth16.1%6.0%10.3%
EPS growth77.5%-12.3%16.5%
Profitability
Net margin19.3%9.1%27.4%
ROE33.8%18.8%24.4%
Balance sheet & cash
Debt / equity0.47x0.97x0.11x
Free cash flow yield1.8%7.7%3.8%
Dividend yield—0.2%1.2%
Verdict
Investment ratingFavorable· 70Neutral· 51Strong· 75

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDXCMtoday $90GEHCtoday $71RMDtoday $233
2027$119.91 – $175.87+95% CAGR$54.48 – $79.91+12% CAGR$203.82 – $298.94+28% CAGR
2028$212.78 – $312.08+86% CAGR$55.57 – $81.51+7% CAGR$237.39 – $348.17+22% CAGR
2029$377.58 – $553.79+83% CAGR$56.68 – $83.14+5% CAGR$276.49 – $405.51+20% CAGR
2030$670.02 – $982.70+82% CAGR$57.82 – $84.80+4% CAGR$322.02 – $472.30+19% CAGR
2031$1,188.96 – $1,743.80+81% CAGR$58.97 – $86.50+4% CAGR$375.06 – $550.09+19% CAGR
5-yr CAGR67.5% – 80.9%-3.7% – 4.0%10.0% – 18.7%